###begin article-title 0
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
Rapid generation of inducible mouse mutants
###end article-title 0
###begin p 1
###xml 95 121 95 121 <email xmlns:xlink="http://www.w3.org/1999/xlink">f.schwenk@artemispharma.de</email>
To whom correspondence should be addressed. Tel: +49 221 9645315; Fax: +49 221 9645321; Email: f.schwenk@artemispharma.de
###end p 1
###begin p 2
###xml 370 374 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 383 387 383 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ</italic>
###xml 230 235 <span type="species:ncbi:10090">mouse</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
###xml 553 558 <span type="species:ncbi:10090">mouse</span>
###xml 641 646 <span type="species:ncbi:10090">mouse</span>
We have generated an optimized inducible recombination system for conditional gene targeting based on a Cre recombinase-steroid receptor fusion. This configuration allows efficient Cre-mediated recombination in most organs of the mouse upon induction, without detectable background activity. An ES cell line, was established that carries the inducible recombinase and a loxP-flanked lacZ reporter gene. Out of this line, completely ES cell-derived mice were efficiently produced through tetraploid blastocyst complementation, without the requirement of mouse breeding. Our findings provide a new concept allowing the generation of inducible mouse mutants within 6 months, as compared to 14 months using the current protocol.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c1">1</xref>
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c3">3</xref>
###xml 317 321 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 556 557 556 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c4">4</xref>
###xml 966 967 966 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c5">5</xref>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 343 348 <span type="species:ncbi:10090">mouse</span>
###xml 1035 1039 <span type="species:ncbi:10090">mice</span>
###xml 1522 1527 <span type="species:ncbi:10090">mouse</span>
Conditional gene targeting has become increasingly used in reverse mouse genetics, as it facilitates setting the site and time of gene inactivation in the body (1-3). This is achieved by the expression of the site-specific DNA recombinase Cre in conjunction with the target gene containing two Cre recognition sites (loxP). In the conditional mouse mutant, inactivation of the target gene is restricted in a spatial and/or temporal manner, depending on the expression pattern of the recombinase. Since the initial demonstration of this technology in 1994 (4), an increasing number of conditional knockout experiments have been published, most of which employed tissue-specific promoters to control Cre expression. Spatially regulated gene inactivation has proven to be powerful in dissecting the role of different cell types in a physiological process, as demonstrated for example by studies concerning the role of insulin receptor signaling in glucose homeostasis (5). The method of choice for precise gene function analyses in adult mice, however, is the temporal control of gene inactivation as it can prevent impaired embryonic development until the time of induction. In particular, inducible gene targeting in all organs would be a useful tool if the major site of gene action is not precisely defined. Optimally, such a system should permit a tight control of gene inactivation, efficient recombination in every single cell of the body upon induction, and the opportunity to produce sufficient numbers of inducible mouse mutants within a short time.
###end p 4
###begin p 5
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 351 352 351 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f5">5</xref>
###xml 754 755 754 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c6">6</xref>
###xml 756 758 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c10">10</xref>
###xml 905 911 905 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa26</italic>
###xml 918 920 918 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c11">11</xref>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 384 389 <span type="species:ncbi:10090">mouse</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
###xml 561 566 <span type="species:ncbi:10090">mouse</span>
###xml 773 778 <span type="species:ncbi:10090">mouse</span>
###xml 1481 1486 <span type="species:ncbi:10090">mouse</span>
The major drawback of the current strategy is the long time frame required for the derivation of a conditional mouse mutant. Since two copies of the loxP-flanked allele must be combined with the recombinase transgene, at least three breeding steps (3 months each) are required to obtain a reasonable number of mice with the desired genotype (see Fig. 5A). While the first conditional mouse mutants can be expected within 14 months, additional time for breeding is usually needed to obtain sufficient numbers of mice for phenotypic analysis. To date, only a few mouse strains permitting ubiquitously inducible gene targeting are available, all of which suffer from incomplete recombination upon induction or background activity in the absence of inducer (6-10). Recently, a mouse strain has been generated by the insertion of a tamoxifen-inducible CreER fusion protein gene into the ubiquitously expressed Rosa26 gene (11). While this strain represented the most efficient tool for ubiquitously inducible gene targeting so far, a low affinity ER domain was used that requires high doses of the inducer 4-hydroxytamoxifen to achieve the maximal rate of recombination. Therefore, the side effects of the inducer may interfere with the phenotypic outcome of target gene inactivation. Taken together, there is a need for improved methods which both enable efficient gene knockout in all organs at non-toxic concentrations of the inducer and which accelerate the production of inducible mouse mutants.
###end p 5
###begin p 6
###xml 293 297 293 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
In this paper we describe a novel approach for the rapid generation of inducible mouse mutants, which overcomes the drawbacks of the current technology. The approach is based on a ubiquitously expressed, high affinity CreER fusion protein that allows the efficient inducible inactivation of a loxP-flanked target gene in most organs. In addition, we demonstrate that hybrid ES cells tolerate at least three consecutive gene targeting cycles including selection with the antibiotics G418 and hygromycin B without affecting the potency to complement tetraploid blastocysts. Our findings provide a new concept allowing the rapid production of ES cell-derived, inducible knockout mice.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
Construction of vectors
###end title 8
###begin p 9
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 5 7 5 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 5 7 5 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 13 16 13 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c12">12</xref>
###xml 558 561 558 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 585 588 585 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1027 1032 1027 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">creER</italic>
###xml 1032 1034 1032 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 1032 1034 1032 1034 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 1087 1090 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1164 1167 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
CreERT2. The Cre gene was amplified by PCR (Expand High Fidelity PCR system; Clontech) from PGKCrebpA using the oligos PR-A (TAACTAGCGGCCGCGTCGACCATGTCC AATTTACTGACCGTACAC) and creER5 (TCTCATGTCT CCAGCAGAATCGCCATCTTCCAGCAGGCG). In parallel the ER domain was amplified from the CreED2 vector (12) using the oligos creER4 (CTGGAAGATGGCGATTCTGC TGGAGACATGAGAGCTGCC) and creER1 (TAGTTAG CGGCCGCTCAGACTGTGGCAGGGAAACCCTC). Both PCR products were used as overlapping templates in a PCR with the primers PR-A and creER1. The resulting 2 kb product was digested with NotI and inserted into the NotI site of pBS. Site-directed mutagenesis (Stratagene) was applied to introduce a G400V mutation using primers ER-G400Vs (CATGGAGCACCCAGTGAAGCTACTGTTTG) and ER-G400Vas (CAAACAGTAGCTTCACTGGGTGCTCCATG). For the introduction of two amino acid changes, M543A/L544A, the primers ER AA2' s EagI (ATGACCTGCTG CTGGAGGCGGCCGACGCCCACCGCCTAC) and ER AA2 as EagI (GTAGGCGGTGGGCGTCGGCCGCCTCCAGCA GCAGGTCAT) were used in a site-directed mutagenesis. The creERT2 was inserted into an expression vector containing a CMV promoter, an intron and a polyadenylation signal resulting in the vector CMV-CreER.
###end p 9
###begin p 10
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa targeting vector.</italic>
###xml 113 119 113 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa26</italic>
###xml 286 289 286 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 326 329 326 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 368 371 368 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sac</italic>
###xml 374 377 374 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 390 393 390 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c13">13</xref>
###xml 142 147 <span type="species:ncbi:10090">mouse</span>
Rosa targeting vector. A 129 SV/EV-BAC library (Incyte Genomics) was screened with a probe against exon 2 of the Rosa26 locus [amplified from mouse genomic DNA using Rscreen1s (GACAGGACAGTGCTTGTTTAAGG) and Rscreen1as (TGACTACACAATATTGCTCGCAC)]. Out of the identified BAC clone an 11 kb EcoRV subfragment was inserted into the HindII site of pBS. Two fragments (a 1 kb SacII-XbaI and a 4 kb XbaI fragment) were used as homology arms and inserted into a vector consisting of a FRT-flanked neomycin resistance gene (unpublished) and a splice acceptor site from adenovirus (13).
###end p 10
###begin p 11
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 5 7 5 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 5 7 5 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 7 23 7 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">knock-in vector.</italic>
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 33 35 33 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
CreERT2knock-in vector. The CreERT2 coding sequence and a polyadenylation site was inserted into the Rosa-targeting vector.
###end p 11
###begin p 12
###xml 0 36 0 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa(lacZ reporter) knock-in vector.</italic>
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c14">14</xref>
###xml 195 199 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 233 237 233 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ</italic>
Rosa(lacZ reporter) knock-in vector. The neo gene of the Rosa-targeting vector was deleted through transformation of FLP-expressing bacteria (14). In the resulting vector a cassette containing a loxP-flanked PGK-hygro-pA followed by lacZ was inserted.
###end p 12
###begin p 13
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ect2 Targeting vector.</italic>
###xml 226 230 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 341 344 341 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 346 349 346 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sgf</italic>
###xml 420 423 420 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 425 428 425 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pme</italic>
###xml 440 444 440 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 538 541 538 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Asc</italic>
###xml 543 546 543 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fse</italic>
###xml 560 564 560 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
ect2 Targeting vector. The vector was generated by insertion of PCR fragments (with attached restriction sites) amplified from BAC DNA (129SVJ) into a vector consisting of a FRT-flanked neomycin resistance gene flanked by two loxP sites (G. Kauselmann, unpublished results). The 989 bp PCR fragment of the 5' targeting arm was inserted with NotI/SgfI 5' of the loxP sites and the 4023 bp PCR fragment of the 3' arm with XhoI/PmeI 3' of the loxP sites. The 428 bp PCR fragment of exon 6 and the flanking intronic region were inserted with AscI/FseI between the loxP sites.
###end p 13
###begin title 14
Cell culture
###end title 14
###begin p 15
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c15">15</xref>
###xml 140 141 140 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
Culture and targeted mutagenesis of ES cells were carried out as previously described (15) with ES cell lines derived from both inbred and F1 embryos.
###end p 15
###begin p 16
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Generation of ect2</italic>
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 18 22 18 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic></sup>
###xml 22 31 22 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ES cells.</italic>
Generation of ect2floxES cells. The C57BL/6 cell line Bruce4 was electroporated with the described targeting vector, and out of 480 clones 3 homologous recombined clones were detected.
###end p 16
###begin title 17
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 17
###begin p 18
###xml 209 212 209 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pol</italic>
###xml 216 220 213 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 216 220 213 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic></sup>
###xml 221 225 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 226 231 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 231 233 228 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 231 233 228 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 239 243 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ect2</italic>
###xml 243 247 240 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 243 247 240 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic></sup>
###xml 248 252 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 253 258 250 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 258 260 255 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 258 260 255 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 297 301 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 302 307 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 307 309 304 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 307 309 304 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 333 334 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c4">4</xref>
###xml 340 344 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ect2</italic>
###xml 344 348 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 344 348 338 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic></sup>
###xml 4 8 <span type="species:ncbi:10090">mice</span>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
All mice were kept in the animal facility at Artemis Pharmaceuticals GmbH in microisolator cages (Tecniplast Sealsave). B6D2F1 mice for the generation of tetraploid blastocysts were obtained from Janvier. The polbetaflox/rosa(CreERT2) and ect2flox/rosa(CreERT2) mice were generated by breeding of rosa(CreERT2) ES mice with betaT14 (4) and ect2flox females (unpublished), respectively.
###end p 18
###begin title 19
###xml 17 21 <span type="species:ncbi:10090">mice</span>
Production of ES mice by tetraploid embryo complementation
###end title 19
###begin p 20
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c16">16</xref>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
The production of mice by tetraploid embryo complementation was essentially performed as described (16).
###end p 20
###begin title 21
Ligand administration
###end title 21
###begin p 22
###xml 332 336 <span type="species:ncbi:10090">mice</span>
An aliquot of 100 mg tamoxifen-free base (T5648; Sigma) was suspended in 100 microl ethanol and dissolved in 1 ml sunflower oil (Sigma). This 10 mg/100 microl tamoxifen solution was sonicated for 1-2 min and then stored at -20degreesC. For p.o. administration the solution was thawed at 55degreesC and administrated to 4-8-week-old mice by a feeding needle (18061-20FST; Fine Science Tools GmbH).
###end p 22
###begin title 23
Western blot analysis
###end title 23
###begin p 24
###xml 260 266 <span type="species:ncbi:9986">rabbit</span>
Western blot analysis was performed using SDS-PAGE (NuPAGE; Invitrogen) and the Breeze Immunodetection System (Invitrogen) according to the manufacturer's protocols. Immunodetection was done using HC-20 against ER, PRB-106C against cre, I-19 against actin and rabbit polyclonal IgG antibodies (Santa Cruz Biotechnology Inc.).
###end p 24
###begin title 25
RESULTS
###end title 25
###begin title 26
###xml 11 12 11 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 44 47 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
Design of F1 ES cells carrying an inducible Cre transgene
###end title 26
###begin p 27
###xml 193 195 193 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T2</sup>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c17">17</xref>
###xml 208 210 208 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T2</sup>
###xml 459 460 459 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c18">18</xref>
###xml 486 491 486 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 491 493 491 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 491 493 491 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 553 559 553 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa26</italic>
###xml 693 694 693 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f1">1</xref>
###xml 701 707 701 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa26</italic>
###xml 740 745 740 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 745 747 745 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 745 747 745 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 775 776 775 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f1">1</xref>
###xml 843 844 843 844 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 886 887 886 887 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1072 1074 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c16">16</xref>
###xml 1195 1196 1195 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f1">1</xref>
###xml 1216 1219 1216 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 1253 1258 1253 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1258 1260 1258 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 1258 1260 1258 1260 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 1317 1318 1317 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f1">1</xref>
###xml 1324 1328 1324 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 1405 1411 1405 1411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa26</italic>
###xml 1418 1419 1418 1419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f1">1</xref>
###xml 1491 1497 1491 1497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa26</italic>
###xml 1508 1510 1508 1510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c19">19</xref>
###xml 1511 1513 1511 1513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c20">20</xref>
###xml 1546 1550 1546 1550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 1551 1556 1551 1556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1556 1558 1556 1558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 1556 1558 1556 1558 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 1568 1572 1568 1572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 1573 1586 1573 1586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ reporter</italic>
###xml 1627 1631 1627 1631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 1726 1727 1726 1727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f1">1</xref>
###xml 1763 1765 1763 1765 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T2</sup>
###xml 1828 1829 1828 1829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f1">1</xref>
###xml 1867 1868 1867 1868 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 1885 1887 1885 1887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c12">12</xref>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 260 265 <span type="species:ncbi:9606">human</span>
###xml 417 421 <span type="species:ncbi:10090">mice</span>
###xml 989 993 <span type="species:ncbi:10090">mice</span>
###xml 998 1002 <span type="species:ncbi:10090">mice</span>
To derive an optimized system for inducible gene targeting in mice, we generated a fusion protein consisting of Cre recombinase and the mutated ligand-binding domain of the estrogen receptor ERT2 (17). The ERT2 domain is composed of amino acids 282-595 of the human estrogen receptor and carries three mutations (G400V/M543A/L544A) that confer a 10x enhanced sensitivity to the synthetic ligand 4-hydroxytamoxifen in mice as compared to the previously used ERT (G521R) domain (18). The CreERT2 coding region was inserted into the ubiquitously expressed Rosa26 locus through homologous recombination to obtain a configuration that allows the inducible inactivation of genes in all organs (Fig. 1). The Rosa26 targeting vector containing the CreERT2 gene is depicted in Figure 1A. We used the hybrid ES cell lines V6.5 [(C57BL/6 x 129S4Sv/Jae) F1] and ART4.12 [(C57BL/6 x 129S6/SvEvTac) F1] for homologous recombination, since these lines are capable of producing completely ES cell-derived mice (ES mice) through tetraploid blastocyst complementation with high efficiency (16). Independent recombinant ES cell clones were obtained at a frequency of 2% as verified by Southern blot analysis (Fig. 1B). Deletion of the neo gene did not affect the level of CreERT2 expression as determined by western blot analysis (Fig. 1D). A loxP-flanked hygromycin resistance gene was introduced into the second allele of Rosa26 (Fig. 1A and C) to provide a similar test substrate for Cre as the widely used Rosa26 reporter (19,20). In ES cells carrying both the rosa(CreERT2) and the rosa(lacZ reporter) alleles, complete recombination of the loxP-flanked segment was achieved upon treatment with 500 nM 4-hydroxytamoxifen for 4.5 days (Fig. 1E). Half-maximal activation of CreERT2 occurred at a concentration of 10 nM 4-hydroxytamoxifen (Fig. 1F) as compared to 100 nM for the CreERT fusion protein (12).
###end p 27
###begin title 28
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Generation of ES cell-derived mice
###end title 28
###begin p 29
###xml 441 442 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f2">2</xref>
###xml 587 592 587 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c16">16</xref>
###xml 605 606 605 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f2">2</xref>
###xml 656 662 656 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa26</italic>
###xml 699 704 699 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 705 709 705 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 863 864 863 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f2">2</xref>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 480 484 <span type="species:ncbi:10090">mice</span>
###xml 713 717 <span type="species:ncbi:10090">mice</span>
###xml 899 903 <span type="species:ncbi:10090">mice</span>
The three types of recombinant and wild-type V6.5 and ART4.12 ES cells were injected into tetraploid blastocysts and ES mice were obtained upon transfer of these blastocysts into pseudopregnant females. The proportion of transferred blastocysts that further developed into live born pups was in the range 8-17% and did not significantly decrease when ES cells were used that had undergone up to three sequential rounds of transfection (Fig. 2A). In contrast, the production of ES mice using inbred ES cells was inefficient (0.2%), confirming the 'hybrid vigor' effect described in Eggan et al. (16) (Fig. 2A). Southern blot analysis of genomic DNA using a Rosa26-specific probe showed that the V6.5/CreER/flox ES mice were indeed solely derived from the recombinant ES cells and did not contain any detectable tetraploid cells from the injected blastocysts (Fig. 2B). These results demonstrate that mice can be produced by tetraploid blastocyst complementation using cells that have undergone three consecutive rounds of transfection, including two drug selection cycles.
###end p 29
###begin title 30
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Ubiquitously inducible gene targeting in mice
###end title 30
###begin p 31
###xml 26 28 26 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T2</sup>
###xml 158 160 158 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c21">21</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c22">22</xref>
###xml 434 438 434 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa</italic>
###xml 439 444 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 444 446 444 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 444 446 444 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 447 460 447 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ reporter</italic>
###xml 538 542 538 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ</italic>
###xml 756 757 756 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f3">3</xref>
###xml 871 883 871 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa26-CreER</italic>
###xml 883 884 883 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 883 884 883 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T</italic></sup>
###xml 893 895 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c11">11</xref>
###xml 920 922 920 922 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T2</sup>
###xml 1002 1006 1002 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ</italic>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 462 466 <span type="species:ncbi:10090">mice</span>
For the induction of CreERT2 in mice, we applied 1-5 mg tamoxifen orally for 5 days in the following experiments. We preferred to use this protocol, as the LD50 of tamoxifen in mice is 15-fold higher via the oral route than by i.p. injection (200 mg versus 5 g/kg) (21). It has been recently demonstrated that the oral application of tamoxifen is as efficient as i.p. injection of 4-hydroxytamoxifen for the activation of CreER (22). Rosa(CreERT2/lacZ reporter) mice were fed with daily 5 mg tamoxifen for 5 days and recombination of the lacZ reporter was analyzed 3 days after the last administration. Southern analysis of genomic DNA from different organs showed up to 50% recombination, without detectable background activity in untreated animals (Fig. 3A). This is a significantly higher degree of inducible recombination as compared to the results obtained with the Rosa26-CreERT strain (11), indicating that the ERT2 domain is indeed more sensitive to 4-hydroxytamoxifen. Upon recombination, the lacZ gene turned out to be inserted non-functionally, presumably due to a second start codon upstream of the coding region.
###end p 31
###begin p 32
###xml 10 16 10 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa26</italic>
###xml 60 62 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c11">11</xref>
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 101 106 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 106 108 106 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 106 108 106 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 148 152 148 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 204 208 204 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 251 254 248 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pol</italic>
###xml 258 262 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 258 262 252 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic></sup>
###xml 265 266 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c4">4</xref>
###xml 340 341 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c4">4</xref>
###xml 342 344 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c12">12</xref>
###xml 345 347 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c23">23</xref>
###xml 348 350 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c26">26</xref>
###xml 386 387 380 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c6">6</xref>
###xml 388 390 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c12">12</xref>
###xml 500 503 494 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pol</italic>
###xml 507 511 498 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 507 511 498 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic></sup>
###xml 512 516 503 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 517 522 508 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 522 524 513 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 522 524 513 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 643 647 634 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 824 825 812 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f3">3</xref>
###xml 868 872 856 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 896 900 884 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ect2</italic>
###xml 996 1000 984 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ect2</italic>
###xml 1000 1004 988 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 1000 1004 988 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic></sup>
###xml 1005 1009 993 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 1010 1015 998 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1015 1017 1003 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 1015 1017 1003 1005 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 1097 1098 1085 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f3">3</xref>
###xml 1173 1177 1161 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 1222 1226 1210 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ect2</italic>
###xml 1247 1248 1235 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f3">3</xref>
###xml 1353 1357 1341 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ect2</italic>
###xml 1357 1361 1345 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 1357 1361 1345 1349 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic></sup>
###xml 1441 1443 1429 1431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T2</sup>
###xml 1451 1458 1439 1446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 813 817 <span type="species:ncbi:10090">mice</span>
###xml 1019 1023 <span type="species:ncbi:10090">mice</span>
Since the Rosa26 locus has a limited accessibility for Cre (11), we were interested to test the rosa(CreERT2) configuration in the context of other loxP-flanked loci. As the second substrate, we used the loxP-flanked DNA polymerase beta gene segment (polbetaflox) (4). This allele had been used to characterize a number of tissue-specific (4,12,23-26) as well as inducible Cre strains (6,12), and shows an intermediate accessibility for Cre (F. Schwenk and J. Seibler, unpublished observations). The polbetaflox/rosa(CreERT2) mice were fed with 5 mg tamoxifen/day for 5 days and analyzed 3 days later. Southern blot analysis revealed that the loxP-flanked polymerase beta gene segment was excised in more than 90% of cells in all organs except brain, whereas no background recombination was detected in untreated mice (Fig. 3B). As a third substrate, we used a 2.5 kb loxP-flanked segment of the ect2 gene. Again, up to 100% recombination in most tissues was achieved upon tamoxifen treatment of ect2flox/rosa(CreERT2) mice, without detectable background recombination in uninduced controls (Fig. 3C). A similar degree of recombination was achieved when a shorter (0.5 kb) loxP-flanked segment in the same position of the ect2 gene was used (Fig. 3D). 'Low dose application' of 5 x 1 mg tamoxifen was sufficient to achieve complete recombination of the ect2flox allele in most organs, further demonstrating the improved sensitivity of the ERT2 domain in vivo.
###end p 32
###begin p 33
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 85 87 85 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 85 87 85 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 230 232 230 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T2</sup>
###xml 362 363 362 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f4">4</xref>
###xml 525 527 525 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T2</sup>
###xml 163 168 <span type="species:ncbi:9606">human</span>
To investigate whether the low recombination efficiency in brain was due to low CreERT2 expression we performed western analysis using antibodies specific for the human estrogen receptor. The 74 kDa band corresponding to the CreERT2 fusion protein was detectable in all organs including brain, with the highest levels in thymus, small intestine and testis (Fig. 4). The limited degree of recombination in brain may thus reflect a lower local concentration of 4-hydroxytamoxifen rather than a reduced expression level of CreERT2.
###end p 33
###begin title 34
DISCUSSION
###end title 34
###begin p 35
###xml 286 292 286 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa26</italic>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c19">19</xref>
###xml 327 339 327 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa26-CreER</italic>
###xml 339 340 339 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 339 340 339 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T</italic></sup>
###xml 374 379 374 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c11">11</xref>
###xml 401 403 401 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T2</sup>
###xml 528 529 516 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 538 540 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c17">17</xref>
###xml 541 543 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c18">18</xref>
###xml 559 563 547 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 564 569 552 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 569 571 557 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 569 571 557 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 643 647 631 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 763 764 751 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f3">3</xref>
###xml 1000 1006 988 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa26</italic>
###xml 1015 1028 1003 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ reporter</italic>
###xml 1113 1118 1101 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 1121 1123 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c11">11</xref>
###xml 1205 1209 1193 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 1210 1215 1198 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1215 1217 1203 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 1215 1217 1203 1205 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 1239 1240 1227 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f2">2</xref>
###xml 1336 1340 1324 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 1362 1366 1350 1354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 1367 1372 1355 1360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1372 1374 1360 1362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 1372 1374 1360 1362 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 341 346 <span type="species:ncbi:10090">mouse</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
###xml 1497 1502 <span type="species:ncbi:10090">mouse</span>
We describe an optimized system that allows ubiquitously inducible gene targeting in mice. This system is based on a fusion protein consisting of Cre recombinase and a mutated ligand-binding domain of the estrogen receptor that is expressed under the control of the ubiquitously active Rosa26 promoter (19). In contrast to the Rosa26-CreERT mouse strain published by Vooijs et al. (11), we used the ERT2 domain that responds at an approximately10-fold lower dose of the synthetic inducer 4-hydroxytamoxifen as compared to the ERT domain (17,18). In mice, the rosa(CreERT2) configuration achieved nearly complete inducible excision of multiple loxP-flanked gene segments in all organs except brain, without background recombination in the absence of inducer (Fig. 3). Thus, our system permits the tight temporal control of ubiquitous gene inactivation, allowing precise gene function analysis in animals that have undergone normal embryonic development. The lower degree of deletion observed with the Rosa26 allele (lacZ reporter) confirms the position dependency of Cre-mediated recombination described by Vooijs et al. (11). Since all other targets tested so far achieved near complete excision with the rosa(CreERT2) configuration (Fig. 2 and unpublished observations), a limited accessibility may be restricted to only a minority of loxP-flanked loci. As the rosa(CreERT2) allele permits inducible gene inactivation in all organs, it should find broad application as a research tool in reverse mouse genetics.
###end p 35
###begin p 36
###xml 72 79 72 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 101 106 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 106 108 106 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 106 108 106 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c16">16</xref>
###xml 1014 1015 1014 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f5">5</xref>
###xml 1041 1046 1041 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1046 1048 1046 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 1046 1048 1046 1048 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 1069 1073 1069 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ</italic>
###xml 1145 1151 1145 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa26</italic>
###xml 1586 1587 1586 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f2">2</xref>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
###xml 628 633 <span type="species:ncbi:10090">mouse</span>
###xml 1352 1356 <span type="species:ncbi:10090">mice</span>
###xml 1822 1826 <span type="species:ncbi:10090">mice</span>
###xml 1855 1860 <span type="species:ncbi:10090">mouse</span>
We have employed the tetraploid blastocyst complementation approach for in vivo analysis of the rosa(CreERT2) configuration, allowing the generation of ES cell-derived mice (ES mice) in a single step without the requirement of time-consuming breeding. Tetraploid blastocysts are not capable of completing normal development, but, when complemented by the introduction of diploid ES cells, support the development of solely ES cell-derived mice. The efficient generation of such ES mice using non-transgenic hybrid ES cells has been recently demonstrated (16). In this study, the authors also succeeded in generating a single ES mouse through tetraploid blastocyst complementation using transfected cells that had undergone two consecutive rounds of selection. However, it remained unclear whether ES cells maintain their potency to complement tetraploid embryos with sufficient efficiency and reproducibility even after additional genetic modifications, which is a prerequisite for the strategy depicted in Figure 5B. We introduced both the CreERT2 coding region and a lacZ reporter construct into hybrid ES cells by targeted insertion into the Rosa26 locus. The targeting strategy involved three consecutive rounds of transfection and selection with the antibiotics G418 and hygromycin B. We found that all targeted ES cell clones produced ES-derived mice with high efficiency. The proportion of transferred blastocysts that developed into live born pups was in the range 8-17% and did not significantly decrease using ES cells that had undergone three consecutive transfections (Fig. 2A). Thus, we demonstrate that hybrid ES cells can be exposed to at least three transfection cycles without affecting the potency to complement tetraploid embryos, allowing the analysis of complex genetic alterations in ES cell-derived mice within the time of a single mouse generation.
###end p 36
###begin p 37
###xml 361 365 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f5">5</xref>
###xml 668 671 668 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c15">15</xref>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c27">27</xref>
###xml 834 838 834 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 937 938 937 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f5">5</xref>
###xml 956 959 956 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 1011 1015 1011 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 1406 1407 1406 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f5">5</xref>
###xml 1596 1597 1596 1597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f5">5</xref>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 202 207 <span type="species:ncbi:10090">mouse</span>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 584 589 <span type="species:ncbi:10090">mouse</span>
###xml 672 687 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1076 1081 <span type="species:ncbi:10090">mouse</span>
###xml 1223 1228 <span type="species:ncbi:10090">mouse</span>
###xml 1367 1372 <span type="species:ncbi:10090">mouse</span>
###xml 1572 1577 <span type="species:ncbi:10090">mouse</span>
###xml 1782 1787 <span type="species:ncbi:10090">mouse</span>
Our findings provide the proof of principle for a new concept allowing the rapid production of inducible knockout mice using tetraploid blastocyst complementation. So far, the derivation of conditional mouse mutants had been a time-consuming undertaking since three breeding steps (3 months each) are usually required to obtain mice combining two copies of the loxP-flanked allele and the recombinase transgene (Fig. 5A). To address this limitation, we propose a new strategy that involves the tetraploid blastocyst complementation approach for the one step generation of conditional mouse mutants from genetically engineered ES cells. The generation of ES cells from Cre transgenic mice is feasible using standard protocols (15), as demonstrated by O'Gorman and colleagues (27). Three transfection cycles are sufficient to introduce loxP sites into both alleles of the target gene in ES cells, following the strategy depicted in Figure 5B. Thus, by using Cre transgenic ES cell lines for the generation of the loxP-flanked alleles, it will be possible to produce conditional mouse mutants directly from the targeted ES cells through tetraploid blastocyst complementation. Using this scheme, adult (2 months old) inducible mouse mutants available for phenotypic analyses can be obtained within 6 months, required for three gene targeting steps (1 month each) and one mouse generation time (3 months) (Fig. 5B). This saves more than 50% of time as compared to the current conditional gene targeting protocol, which requires 14 months including two targeting steps and four mouse generations (Fig. 5A). Since the described approach is simple and technically not more demanding than the current knockout protocol, we expect that this strategy will become a widely used tool in reverse mouse genetics.
###end p 37
###begin title 38
Figures and Tables
###end title 38
###begin p 39
###xml 35 36 35 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 129 135 129 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa26</italic>
###xml 186 189 186 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 196 199 196 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 206 209 206 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bgl</italic>
###xml 213 214 213 214 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 310 312 310 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 310 312 310 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 423 426 423 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bgl</italic>
###xml 503 506 499 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 555 556 551 552 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 649 653 645 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 654 659 650 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 659 661 655 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 659 661 655 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 667 671 663 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 672 685 668 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ reporter</italic>
###xml 728 734 724 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa26</italic>
###xml 761 764 757 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 892 893 888 889 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 925 927 921 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T2</sup>
###xml 977 980 973 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 1080 1081 1076 1077 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 1140 1144 1136 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 1145 1158 1141 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ reporter</italic>
###xml 1266 1269 1262 1265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 1309 1315 1305 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa26</italic>
###xml 1351 1352 1347 1348 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 1508 1511 1504 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 1551 1557 1547 1553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa26</italic>
 Generation of targeted ES cells. (A) Scheme of the gene targeting strategy. Both constructs were sequentially inserted into the Rosa26 locus by homologous recombination as depicted. E, EcoRV; X, XbaI; Bg, BglI. (B) Southern blot analysis of genomic DNA from ES cells containing the targeted insertion of CreERT2 before and after FLP-mediated deletion of the neomycin resistance gene. The DNA of ES cells was digested with BglI and hybridized with probe 2. The sizes of the wild-type, targeted and Deltaneo alleles are 6.6, 7.6 and 9.0 kb, respectively. (C) Southern blot analysis of genomic DNA extracted from double-targeted ES cells carrying the rosa(CreERT2) and rosa(lacZ reporter) alleles. Homologous recombination at the Rosa26 locus is detectable using EcoRV-digested genomic DNA and probe 1, resulting in an 11.7 kb band for the wild-type and a 2.5 kb band for the targeted allele. (D) Western blot analysis of CreERT2 expression in targeted ES cells before and after neo deletion. The western blot was probed with a Cre antiserum as described in Materials and Methods. (E) Southern blot analysis of inducible recombination of the rosa(lacZ reporter) allele. Cells were treated for 4.5 days with 500 nM 4-hydroxytamoxifen (4-OHT). Southern blot analysis of EcoRV-digested DNA was performed using the rosa26-specific probe 1 depicted in (A). (F) Titration of 4-OHT inducible recombination. Cells were treated for 3 days with increasing concentrations of 4-OHT as indicated. Southern blot analysis of EcoRV-digested DNA was performed using the rosa26-specific probe 1.
###end p 39
###begin p 40
###xml 60 61 60 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 227 228 227 228 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 401 404 401 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 427 433 427 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa26</italic>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gng012f1">1</xref>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
###xml 342 347 <span type="species:ncbi:10090">mouse</span>
 Production efficiency of completely ES cell-derived mice. (A) ES cells with the indicated genotype were injected into tetraploid blastocysts. The percentages of blastocysts that developed into live born ES pups are depicted. (B) Southern blot analysis of DNA extracted from liver of ES mice (lanes 2-9). Genomic tail DNA from a wild-type ES mouse is used as a control (lane 1). DNA was digested with EcoRV and probed with the Rosa26-specific probe 1 as depicted in Figure 1A.
###end p 40
###begin p 41
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 183 187 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 266 267 266 267 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 269 273 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosa</italic>
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 279 281 279 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 279 281 279 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 282 295 282 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ reporter</italic>
###xml 353 356 353 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 381 385 381 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ</italic>
###xml 437 441 437 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 517 518 517 518 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 520 523 520 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pol</italic>
###xml 527 531 524 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 527 531 524 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic></sup>
###xml 532 536 529 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 537 542 534 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 542 544 539 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 542 544 539 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 588 592 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 693 696 690 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 766 767 760 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gng012c4">4</xref>
###xml 771 772 765 766 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 774 778 768 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ect2</italic>
###xml 778 782 772 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 778 782 772 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic></sup>
###xml 783 787 777 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 788 793 782 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 793 795 787 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 793 795 787 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 807 811 801 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 862 865 856 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRT</italic>
###xml 918 922 912 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ect2</italic>
###xml 996 999 990 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hpa</italic>
###xml 1024 1028 1018 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ect2</italic>
###xml 1072 1076 1066 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 1094 1095 1088 1089 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 1097 1101 1091 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ect2</italic>
###xml 1101 1105 1095 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 1101 1105 1095 1099 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic></sup>
###xml 1110 1113 1100 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 1110 1113 1100 1103 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>neo</italic></sup>
###xml 1114 1118 1104 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 1119 1124 1109 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1124 1126 1114 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 1124 1126 1114 1116 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 1138 1142 1128 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ect2</italic>
###xml 1142 1146 1132 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 1142 1146 1132 1136 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic></sup>
###xml 1151 1154 1137 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 1151 1154 1137 1140 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>neo</italic></sup>
###xml 1248 1252 1234 1238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ect2</italic>
###xml 1252 1256 1238 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 1252 1256 1238 1242 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic></sup>
###xml 1279 1283 1265 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 1334 1338 1320 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ect2</italic>
###xml 1412 1415 1398 1401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hpa</italic>
###xml 1440 1444 1426 1430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ect2</italic>
###xml 1462 1463 1448 1449 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 1465 1469 1451 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ect2</italic>
###xml 1469 1473 1455 1459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 1469 1473 1455 1459 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic></sup>
###xml 1474 1478 1460 1464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 1479 1484 1465 1470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1484 1486 1470 1472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 1484 1486 1470 1472 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 1563 1566 1549 1552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hpa</italic>
###xml 1591 1595 1577 1581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ect2</italic>
###xml 1639 1643 1625 1629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 34 38 <span type="species:ncbi:10090">Mice</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 546 550 <span type="species:ncbi:10090">mice</span>
###xml 797 801 <span type="species:ncbi:10090">mice</span>
###xml 1128 1132 <span type="species:ncbi:10090">mice</span>
###xml 1488 1492 <span type="species:ncbi:10090">mice</span>
 Inducible recombination in mice. Mice carrying different loxP-flanked alleles were fed daily with 5 mg tamoxifen (A-D) or 1 mg tamoxifen (E) for 5 days. Cre-mediated deletion of the loxP-flanked region was detected by Southern analysis 3 days after the treatment. (A) Rosa(CreERT2/lacZ reporter) mice. Genomic DNA from various organs was digested with EcoRV and hybridized with a lacZ-specific probe. The percentages of deletion of the loxP-flanked allele, as quantified with a Bio-Imaging Analyzer, are indicated. (B) polbetaflox/rosa(CreERT2) mice. Cre-mediated excision of the 1.5 kb loxP-flanked region was detected by Southern analysis. Genomic DNA from various organs was digested with BamHI and hybridized with a probe specific for the polymerase beta gene (4). (C) ect2flox/rosa(CreERT2) mice. The loxP sites are 2.5 kb apart from each other flanking a FRT-flanked neomycin selection marker and exon 6 of the ect2 gene (described in Materials and Methods). Genomic DNA was digested with HpaI and hybridized with an ect2-specific probe hybridizing upstream of the loxP-flanked region. (D) ect2floxDeltaneo/rosa(CreERT2) mice. The ect2floxDeltaneo allele was generated through FLP-mediated deletion of the neomycin selection marker from the ect2flox allele resulting in a loxP-flanked region of 0.5 kb containing exon 6 of the ect2 gene (described in Materials and Methods). Genomic DNA was digested with HpaI and hybridized with an ect2-specific probe. (E) ect2flox/rosa(CreERT2) mice treated with 1 mg tamoxifen for 5 days. Genomic DNA was digested with HpaI and hybridized with an ect2-specific probe hybridizing upstream of the loxP-flanked region. Li, liver; Sp, spleen; Ki, kidney; He, heart; Lu, lung; Th, thymus; Mu, muscle; Si, small intestine; Br, brain; Te, testis; Co, colon.
###end p 41
###begin p 42
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 31 33 31 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 31 33 31 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 91 96 91 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 96 98 96 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 96 98 96 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 205 209 205 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rosa</italic>
###xml 210 215 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 215 217 215 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T2</italic>
###xml 215 217 215 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T2</italic></sup>
###xml 300 302 300 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T2</sup>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
 Western blot analysis of CreERT2 expression in ES mice. Proteins were extracted from rosa(CreERT2) targeted ES mice and analyzed as described in Materials and Methods. Protein extracts from wild-type and rosa(CreERT2) targeted ES cells are used as controls. The positions of bands representing CreERT2 and actin are indicated. Li, liver; SP, spleen; Ki, kidney; He, heart; Lu, lung; Th, thymus; Mu, muscle; Si, small intestine; Br, brain; Fa, fat tissue; Te, testis.
###end p 42
###begin p 43
###xml 116 117 116 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 219 222 219 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 361 365 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 762 763 762 763 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 466 471 <span type="species:ncbi:10090">mouse</span>
###xml 542 557 <span type="species:ncbi:10090">transgenic mice</span>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
###xml 1119 1124 <span type="species:ncbi:10090">mouse</span>
 The generation of inducible mouse mutants via the current protocol and via tetraploid blastocyst complementation. (A) The current protocol includes the generation of targeted ES cells, the FLP-mediated deletion of the neo gene, the production of chimeric mice, the breeding for germline transmission and another two breeding steps to combine two copies of the loxP-flanked allele with the recombinase transgene. Following this scheme, the generation of conditional mouse mutants usually takes 14 months. Chimeras can be directly bred to Cre transgenic mice supposing that appropriate Cre strains on pure genetic backgrounds are available that allow the detection of germline transmission by coat color. This would save 3 months required for one breeding step. (B) The new approach uses hybrid ES cells carrying the Cre gene with an appropriate expression pattern for conditional gene inactivation in mice. Following the introduction of loxP sites into both alleles of the target gene, the FLP-mediated deletion of the selection marker genes and the injection of these ES cells into tetraploid blastocysts, conditional mouse mutants are obtained within 6 month. The time required for each step is indicated.
###end p 43
###begin title 44
ACKNOWLEDGEMENTS
###end title 44
###begin p 45
We thank Francis Stewart (MPI for Cell Biology and Genetics, Dresden), Frank Edenhofer, Thomas Wunderlich (Institute for Genetics, University of Cologne) and Sandra Niehaves (Artemis Pharmaceuticals, Cologne) for scientific discussions and technical advice. We are grateful to Gordon Stott and Jens Tampe (Artemis Pharmaceuticals, Cologne) for critically reading the manuscript. This work was supported by the German Ministry for Education and Science (BMBF) grant no. 0311956.
###end p 45
###begin title 46
REFERENCES
###end title 46

